125 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
SURGICAL DRAPES
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
CATHETER, SINGLE PUNCTURE Y
FDA 510(k)
FDA Class 2
·Gastroenterology, Urology
Lithotriptor, Extracorporeal Shock-Wave, Urological
FDA Pre-Market Approval
FDA Class 2
·DORNIER LITHOTRIPTER (STATIONARY AND MOBILE)
FENESTRA HOOK
FDA 510(k)
FDA Class 2
·Radiology
SAFECARE Fentanyl Urine Test Cassette; SAFECARE FYL Urine Test Cassette
FDA 510(k)
FDA Class 2
·Clinical Toxicology
ENSEAL TISSUE SEALING DEVICES MODEL: NSEAL514H-535H, NSEAL514RH-535RH
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Co2 Laser System, Models: PureLase And VanLase
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
Graft, Vascular, Synthetic/Biologic Composite
FDA Pre-Market Approval
FDA Class 2
·VASCUTEK GELSOFT(TM) VASCULAR GRAFT
Graft, Vascular, Synthetic/Biologic Composite
FDA Pre-Market Approval
FDA Class 2
·VASCUTEK GELSOFT(TM) VASCULAR GRAFT
Graft, Vascular, Synthetic/Biologic Composite
FDA Pre-Market Approval
FDA Class 2
·VASCUTEK GELSEAL(TM) VASCULAR GRAFT
Graft, Vascular, Synthetic/Biologic Composite
FDA Pre-Market Approval
FDA Class 2
·VASCUTEK GELSEAL(TM) VASCULAR GRAFT
Accessories, Solution, Ultrasonic Cleaners For Lenses
FDA Pre-Market Approval
FDA Class 2
·UNIZYME(TM) ENZYMATIC CLEANER
Graft, Vascular, Synthetic/Biologic Composite
FDA Pre-Market Approval
FDA Class 2
·GELSEAL TM TRIAXIAL VASCULAR GRAFT
Graft, Vascular, Synthetic/Biologic Composite
FDA Pre-Market Approval
FDA Class 2
·ALBUMIN COATED DEBAKEY(R) VASCULAR(R) VASCULAR-II
DSPS-Prominent Masks; DSPS-Prominent Baseplate, MR; CouchStrip
FDA 510(k)
FDA Class 2
·Radiology
VacuumCushions, FeetSupports, LEPS (Lower Extermities Positioning System), CouchStrips
FDA 510(k)
FDA Class 2
·Radiology
FlexBoardTM, EagleBoardTM, BreastBoard SXTM
FDA 510(k)
FDA Class 2
·Radiology
Analyzer, Medical Image
FDA classification
FDA Class 2
·Analyzer, Medical Image
Media, Reproductive, Exempt
FDA classification
FDA Class 2
·Media, Reproductive, Exempt
Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers
FDA classification
FDA Class 2
·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers